MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

Somatic mutations in TP53 are seen in many human cancers. In addition, the protein product of the wild-type TP53 can be sequestered by the protein MDM2 (murine double minute 2). This protein is commonly overexpressed in human sarcomas and gliomas, usually as a result of gene amplification. In this s...

Full description

Saved in:

Bibliographic Details
Main Authors:	Foulkes, W. D., Stamp, G. W., Afzal, S., Lalani, N., McFarlane, C. P., Trowsdale, J., Campbell, I. G.
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 1995
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2034047/ https://ncbi.nlm.nih.gov/pubmed/7547235
Tags:	Add Tag No Tags, Be the first to tag this record!

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

Similar Items